Current Study Trials
Alumis: Oral treatment for moderate to severe Plaque Psoriasis
Arrowhead: Injectable treatment for Hypertriglyceridemia
AstraZeneca: Inhalation treatment for mild to moderate Asthma in children and adults
AstraZeneca: RSV/hMPV vaccine for adults age 60 and older
Eli Lilly: Oral treatment for moderate to severe Alopecia Areata for ages 6 to 17
Incyte: Topical treatment for mild, moderate, or severe Prurigo Nodularis
Pfizer: Oral treatment for Non-segmental Vitiligo
Regeneron: Injectable/Intravenous treatment for Obesity
Sanofi: Pneumococcal vaccine for infants and toddlers
If you have any questions regarding any of the trials listed here, please do not hesitate to contact us at 574−204−6192 or research@southbendclinic.com.